Filters

Anti-Human PAI-1

Anti-Human PAI-1 size: 100ug 290

Price 290
Size 100ug
Gene NamePAI-1
Species ReactivityHuman (Homo sapiens)
SynonymsPAI-1
UniprotP05121
Description this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against
Storage and handling Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene Elevated PAI-1 is a risk factor for , (PAI-1) also known as , Plasminogen activator inhibitor-1 , SERPINE1 , and , atherosclerosis, endothelial plasminogen activator inhibitor , gene, is a , or , protein , serpin E1 , that in humans is encoded by the , thrombosis 
Gene targetPAI-1
Short nameAnti- PAI-1
Species Humans, Human
Alternative name sapiens PAI-1, antibody to-H

Subscribe to our Newsletter